Entero Healthcare Solutions Limited IPO
Founded in 2018, Entero Healthcare Solutions Limited is a company in India that distributes healthcare products. They use technology to deliver these products to pharmacies, hospitals, and clinics all over the country.
Over the last three years, they have served increasing numbers of retail customers, reaching 81,400 in 2023, and have also expanded their services to hospitals.
Entero Healthcare Solutions has partnerships with over 1,900 healthcare product manufacturers, giving them access to a wide range of products.
With 73 warehouses in 37 cities across 19 states and union territories, they serve a vast customer base of over 81,400 pharmacies and 3,400 hospitals across 495 districts.
As of March 31, 2023, the company has a workforce of 3014 employees working in different departments.
Key Points Regarding Entero Healthcare Solutions IPO
| IPO Date | February 9, 2024 to February 13, 2024 |
| Price Band | ₹1195 to ₹1258 per share |
| Face Value | Rs 10 per share |
| Lot Size | 11 Shares |
| Total Issue Size | 12,718,600 shares (aggregating up to ₹1,600.00 Cr) |
| Listing Date | Friday, February 16, 2024 |
| Listing At | BSE, NSE |
Entero Healthcare Solutions IPO Details
- Entero Healthcare Solutions IPO aims to raise Rs 1,600.00 crores through a book built issue.
- The IPO includes a fresh issue of 0.79 crore shares worth Rs 1,000.00 crores and an offer for sale of 0.48 crore shares worth Rs 600.00 crores.
- Subscription for the Entero Healthcare Solutions IPO opens on February 9, 2024, and closes on February 13, 2024.
- Allotment of shares is expected to be finalized on Wednesday, February 14, 2024.
- The IPO will be listed on both the BSE and NSE with a tentative listing date set for Friday, February 16, 2024.
- The price band for the Entero Healthcare Solutions IPO is set between ₹1195 to ₹1258 per share.
- The minimum lot size for an application is 11 shares, requiring a minimum investment of ₹13,838 for retail investors.
- Qualified Institutional Buyers (QIBs) need to apply for a minimum of 15 lots (165 shares), amounting to ₹207,570, while Non-Institutional Investors (NIIs) need to apply for a minimum of 73 lots (803 shares), amounting to ₹1,010,174.
Entero Healthcare Solutions Limited Financial Information (Restated Consolidated)
Between March 31, 2022, and March 31, 2023, Entero Healthcare Solutions Limited’s income grew by about 30.84%, and its profit after tax went up by approximately 62.28%. (Amount in ₹ Crore)
| Period Ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 1,505.95 | 1,308.73 | 1,125.98 | 833.79 |
| Revenue | 1,898.98 | 3,305.72 | 2,526.55 | 1,783.67 |
| Profit After Tax | 11.64 | -11.10 | -29.44 | -15.35 |
| Net Worth | 660.54 | 597.66 | 563.22 | 487.06 |
| Total Borrowing | 488.68 | 373.52 | 285.03 | 141.70 |
Contact Details
Entero Healthcare Solutions Limited
Plot No. I-35, Building – B
Industrial Area Phase – I
13/7 Mathura Road, Faridabad 121 003
Phone: +91 22-69019100
Email: [email protected]
Website: https://www.enterohealthcare.com/
You May Like :
Rashi Peripherals IPO: Price, Detail, GMP, Opening Date, Financial Report and More
Jana Small Finance Bank Limited IPO: Price, Detail, GMP, Opening Date, Financial Report and More